Pfizer announced Wednesday an additional half billion dollar investment and about 300 new jobs at a new state-of-the-art gene therapy manufacturing facility in Sanford.
The announcement came during a news conference led by Gov. Roy Cooper at the Sanford site on Hawkins Avenue as the company celebrated the completion of the first phase of the project. The new facility is anticipated to support Pfizer’s continuing investment in gene therapy research and development, similar to Pfizer’s Chapel Hill and Kit Creek, North Carolina research and development sites. This facility would expand the company’s presence in North Carolina, where there are currently more than 3,600 Pfizer colleagues, including 650 in Sanford. With the expansion, the facility is projected to add approximately 300 new jobs.